Literature DB >> 19996546

Reactive airway dysfunction syndrome (RADS) in a chemistry teacher induced by fumes of mixed iodine compounds.

Timo Hannu1, Vesa Riihimäki, Päivi Piirilä.   

Abstract

The reactive airway dysfunction syndrome (RADS) is a type of occupational asthma without a latency period, and it is induced by irritating vapour, fume, or smoke. Although the onset of RADS has been related to over 30 different agents, it has not been previously associated with acute exposure to iodine, aluminium iodide, or hydrogen iodide. The diagnosis was based on exposure data, clinical symptoms and signs, as well as respiratory function tests and bronchoscopy. A 48-yr-old non-atopic, never-smoking female chemistry teacher developed respiratory symptoms immediately after a demonstration of oxidation-reduction reactions in a school classroom. Spirometry showed bronchial obstruction, and the histamine challenge test revealed bronchial hyperresponsiveness. These findings were still evident seven years after the incident. The prognosis of RADS was unfavourable: the patient had to quit her job as a teacher. A case of RADS following acute exposure to mixed iodine compounds is presented for the first time. Demonstrations of potentially dangerous chemical reactions should always be carried out in a fume cupboard, and appropriate personal protective equipment should be worn.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19996546     DOI: 10.2486/indhealth.47.681

Source DB:  PubMed          Journal:  Ind Health        ISSN: 0019-8366            Impact factor:   2.179


  2 in total

1.  Inhalational exposure to dimethyl sulfate vapor followed by reactive airway dysfunction syndrome.

Authors:  Abbas Aghabiklooei; Nasim Zamani; Hamidreza Shiva; Nader Rezaei
Journal:  Indian J Occup Environ Med       Date:  2010-09

2.  First reported case of reactive airway dysfunction syndrome in a laborer due to porcelain tile dust.

Authors:  Tasleem Arif; Javid Ahmad Malik; Sheikh Shoib
Journal:  Iran J Med Sci       Date:  2013-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.